date/time interval
- May 2, 2024 - April 30, 2025
Development of Small Molecule therapeutics targeting AR-V7 for prostate cancer.
Grant
Overview
awarded by
administered by
sponsor award ID
- 1 R42 CA290913-01
Affiliation
contributor
- Giannakakou, Paraskevi Principal Investigator (Subaward) 2024 - 2025
- Zhou, Xi Kathy Key Personnel 2024 - 2025